HR+/HER2- Breast Cancer Clinical Trials in Fairfax, Virginia
2 recruitingFairfax, Virginia
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
HR+/HER2- Breast Cancer
Avenzo Therapeutics, Inc.380 enrolled11 locationsNCT06998407
Recruiting
Phase 1Phase 2
Study of AVZO-021 in Patients With Advanced Solid Tumors
Advanced Solid TumorHR+/HER2- Breast Cancer
Avenzo Therapeutics, Inc.430 enrolled13 locationsNCT05867251